Rika Wakao

5PUBLICATIONS
7CO-AUTHORS
Molecular targetsPharmacogenomicsDisease surveillance
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

Sort by Publication Date:
|Jun 19, 2026
Challenges in Implementing Revocation of Oncology Drugs Under Conditional Early Approval in Japan: Regulatory Insights From Comparisons With FDA/EMA.

|Oct 27, 2022
Analysis and enhancement of risk management for ethnic differences in antineoplastic drugs in Japan.

Shinobu Uzu, Jun Sato, Rika Wakao

|Apr 10, 2021
The Use of Subgroup Disproportionality Analyses to Explore the Sensitivity of a Global Database of Individual Case Safety Reports to Known Pharmacogenomic Risk Variants Common in Japan.

Rika Wakao, Ingrid M Lönnstedt, Yasunori Aoki

|Jul 04, 2020
Interstitial Lung Disease as an Adverse Drug Reaction in Japan: Exploration of Regulatory Actions as a Basis for High Reporting.

Eiko Iwasa, Yu Fujiyoshi, Yuki Kubota

Pageof 1

Frequent Collaborators

1 joint publications

Henric Taavola

1 joint publications

Yasunori Aoki

1 joint publications

Rebecca E Chandler

1 joint publications

Shinobu Uzu

1 joint publications

Takahiro Handa

1 joint publications

Arata Tanaka

1 joint publications

Mayumi Shikano

Frequent Collaborators

1 joint publications

Henric Taavola

1 joint publications

Yasunori Aoki

1 joint publications

Rebecca E Chandler

1 joint publications

Shinobu Uzu

JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us